Cleancard Analysis
What is Cleancard?
Numen says it is building infrastructure aimed at driving cancer mortality toward zero. Its site describes rapid at-home diagnostics, high-volume health data collection, and proprietary models for earlier intervention and better outcomes. The homepage currently states the company is launching soon.
Revenue
$1.1M
Product Features & Capabilities
- At-home cancer detection tests, urine-based diagnostics, results in 30 minutes, detects multiple cancer biomarkers, 10x quicker and cheaper than lab tests, highly sensitive biomarker-guided diagnostics.
Who are the founders of Cleancard
LS
Luca Springer
Founder
TC
Thomas Carroll
Founder
Market Focus
Cleancard primarily focuses on the healthcare industry, specifically in the field of cancer detection through the integration of synthetic biology and artificial intelligence.
Investors
- Urban Innovation Fund
- Y Combinator
- TQ Ventures
- Creative Destruction Lab
Business Model
Bootstrapped revenue from at-home cancer screening kits using synthetic biology and AI.
See something that needs updating? Suggest edits to this profile.